Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters

Kei Kunimasa(Kobe University), Yoshihiro Nishimura(Kobe University)
Cancer Science
April 26, 2017
Cited by 37


Related Papers